Thyrocare’s 18 labs bags NABL accreditation across India

Recently accreditation were received for nine additional processing laboratories in Bhopal, Guwahati, Bengaluru, Chennai, Patna, Bhubaneswar, Raipur, Lucknow and Ranchi Thyrocare has achieved National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation for nine additional processing laboratories in Bhopal, Guwahati, Bengaluru, Chennai, Patna, Bhubaneswar, Raipur, Lucknow and Ranchi. With this accomplishment, Thyrocare now has a total of 18 NABL-accredited labs across India, a remarkable 64 per cent of its entire lab network is NABL-accredited, and this number continues to rise.  Additionally, a recent survey conducted to gain insight into the perspective of doctors regarding chain diagnostic facilities with a specific focus on the accuracy of lab reports showed that nine out of 10 doctors considered Thyrocare's reports accurate and reliable. This survey which was conducted PAN-India and included doctors from various specialties was published in the International Journal Of Advance Research, Ideas And Innovations In Technology (IJARIIT) in May 2023. This reinforces Thyrocare's commitment to quality and highlights its reputation for delivering precise, dependable and high-quality test results.   Dr Preet Kaur, Vice President - Lab Operations & Quality, Thyrocare, said, “NABL accreditation of 18 labs has resulted in 85 per cent of samples being processed in NABL-accredited labs. This reinforces our commitment to delivering high-quality services at affordable prices.” In addition to NABL accreditation, Thyrocare is also accredited by other esteemed national and international bodies such as the College of American Pathologists (CAP), the International Organization for Standardization (ISO) and the National Glycohemoglobin Standardization Program (NGSP). With a team of over 50 experts MD pathologists stationed across all labs, Thyrocare maintains its devotion to excellence by personally overseeing critical reports and addressing any grievances promptly.  Rahul Guha, MD and CEO, Thyrocare, said, “Our steadfast dedication to providing top-notch services is reflected in our meticulous approach, which includes rigorous quality checks at every stage of the sample journey, from collection to lab processing and customer reporting. With the integration of cutting-edge technologies and a well-trained team, Thyrocare continues to set the industry standard for excellence in diagnostics."  Thyrocare’s quality transformation process includes a 10-point road map that encompasses various crucial stages of the sample journey. From strict quality checks during sample collection through audited phlebotomists to maintaining the cold chain in the mid-mile and ensuring precision in sample processing through continuous equipment upgrades, Thyrocare leaves no stone unturned to guarantee the accuracy and integrity of its services.